Pfizer’s buyout bid for Metsera was deemed inferior to the latest bid from Novo Nordisk, putting the original agreement in ...

Third-quarter results will be the first for Mike Doustdar who was tasked in August with turning around the Danish company's ...

Pfizer and Novo Nordisk are in a heated legal and bidding war over Metsera, an obesity drug developer. Novo's $10 billion bid ...

The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...

Pfizer on Tuesday raised its full-year profit forecast for the second quarter in a row as robust demand for its blockbuster ...

In a stunning twist, Novo Nordisk blindsides Pfizer in the obesity drug race--sparking one of pharma's boldest takeover ...